Cis-dichlorodiammineplatinum (II) and VP
β
Goldhirsch, Aron ;Joss, Rudolf A. ;Cavalli, Franco ;Sonntag, Roland W. ;Brunner,
π
Article
π
1981
π
John Wiley and Sons
π
English
β 230 KB
## Abstract Twentyβthree patients with nonβsmall cell lung cancer were treated with a combination of cisβdichlorodiammineplatinum(II) 100 mg/m^2^ IV on day 1 and VP 16β213 80 mg/m^2^ IV on days 1β3. Eighteen patients are evaluable for response. Seven partial remissions with a median duration of 3 m